Cargando…

Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors

In the past, patients with severe hemophilia have suffered a substantially reduced quality of life with frequent bleeding episodes, disabling arthropathy, and shorter life expectancy. In addition, methods of treatment and management have been costly and time-consuming, and have placed a considerable...

Descripción completa

Detalles Bibliográficos
Autores principales: Saba, Hussain I, Tran, Duc Quang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370834/
https://www.ncbi.nlm.nih.gov/pubmed/22715320
http://dx.doi.org/10.2147/JBM.S30479
_version_ 1782235149316915200
author Saba, Hussain I
Tran, Duc Quang
author_facet Saba, Hussain I
Tran, Duc Quang
author_sort Saba, Hussain I
collection PubMed
description In the past, patients with severe hemophilia have suffered a substantially reduced quality of life with frequent bleeding episodes, disabling arthropathy, and shorter life expectancy. In addition, methods of treatment and management have been costly and time-consuming, and have placed a considerable burden on patients’ physical and psychological well-being. With the advent of the on-demand therapy and prophylactic treatment paradigm, patients have been able to receive care with less interruption of daily activities. Treatments may be more challenging for hemophiliacs with inhibitors to replacement factor; however, recent advances in the use of bypassing agents and immune tolerance therapy have enabled them to aggressively manage their disease while maintaining their independence. This review focuses on the challenges of treating such a severe hemophiliac through examination of the lifetime experience of a young adult male with a severe form of congenital hemophilia A. At this stage of his life, the patient has minimal disabilities and is inhibitor-free through optimal care and strong family support. His aspiration to pursue a productive life has led him to a career in medicine. After receiving his medical degree, he pursued a specialty in the treatment of hemophilia. By assisting other hemophilia patients, he exemplifies both the rewards of persevering through episodes of bleeding and other complications and the fact that disabilities can be minimized when managed meticulously and in a timely fashion to enable a productive and dignified life.
format Online
Article
Text
id pubmed-3370834
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-33708342012-06-19 Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors Saba, Hussain I Tran, Duc Quang J Blood Med Review In the past, patients with severe hemophilia have suffered a substantially reduced quality of life with frequent bleeding episodes, disabling arthropathy, and shorter life expectancy. In addition, methods of treatment and management have been costly and time-consuming, and have placed a considerable burden on patients’ physical and psychological well-being. With the advent of the on-demand therapy and prophylactic treatment paradigm, patients have been able to receive care with less interruption of daily activities. Treatments may be more challenging for hemophiliacs with inhibitors to replacement factor; however, recent advances in the use of bypassing agents and immune tolerance therapy have enabled them to aggressively manage their disease while maintaining their independence. This review focuses on the challenges of treating such a severe hemophiliac through examination of the lifetime experience of a young adult male with a severe form of congenital hemophilia A. At this stage of his life, the patient has minimal disabilities and is inhibitor-free through optimal care and strong family support. His aspiration to pursue a productive life has led him to a career in medicine. After receiving his medical degree, he pursued a specialty in the treatment of hemophilia. By assisting other hemophilia patients, he exemplifies both the rewards of persevering through episodes of bleeding and other complications and the fact that disabilities can be minimized when managed meticulously and in a timely fashion to enable a productive and dignified life. Dove Medical Press 2011-05-18 /pmc/articles/PMC3370834/ /pubmed/22715320 http://dx.doi.org/10.2147/JBM.S30479 Text en © 2012 Saba and Tran, Jr, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Saba, Hussain I
Tran, Duc Quang
Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors
title Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors
title_full Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors
title_fullStr Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors
title_full_unstemmed Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors
title_short Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors
title_sort challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia a and high-titer inhibitors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370834/
https://www.ncbi.nlm.nih.gov/pubmed/22715320
http://dx.doi.org/10.2147/JBM.S30479
work_keys_str_mv AT sabahussaini challengesandsuccessesinthetreatmentofhemophiliathestoryofapatientwithseverehemophiliaaandhightiterinhibitors
AT tranducquang challengesandsuccessesinthetreatmentofhemophiliathestoryofapatientwithseverehemophiliaaandhightiterinhibitors